Back
Travere Therapeutics Quote, Financials, Valuation and Earnings
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Sell
29
TVTX
Travere Therapeutics
Last Price:
6.2600
Seasonality Move:
-0.72%
7 Day Trial
ALL ACCESS PASS
$
7
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.Travere Therapeutics Price Quote
$6.2600
Travere Therapeutics Key Stats
Sell
29
Travere Therapeutics (TVTX)
is a Sell
Day range:
$6.1800 - $6.5600
52-week range:
$5.1200 - $19.5424
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.34
P/B ratio:
2.37%
Volume:
767.1K
Avg. volume:
1.3M
1-year change:
-60.65%
Market cap:
$476.4M
Revenue:
$145.2M
EPS:
$-1.61
How Much Does Travere Therapeutics Make?
-
How Much Are Travere Therapeutics's Sales Annually?
TVTX Revenues are $145.2M -
How Much Profit Does Travere Therapeutics's Make A Year?
TVTX net income is -$111.4M
Is Travere Therapeutics Growing As A Company?
-
What Is Travere Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.54% -
What Is Travere Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Travere Therapeutics Stock Price Performance
-
Did Travere Therapeutics Stock Go Up Last Month?
Travere Therapeutics share price went down by -10.32% last month -
Did TVTX's Share Price Rise Over The Last Year?
TVTX share price fell by -60.65% over the past 1 year
What Is Travere Therapeutics 52-Week High & Low?
-
What Is Travere Therapeutics’s 52-Week High Share Price?
Travere Therapeutics has traded as high as $19.5424 over the past 52 weeks -
What Is Travere Therapeutics’s 52-Week Low Share Price?
Travere Therapeutics has traded as low as $5.1200 over the past 52 weeks
Travere Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Travere Therapeutics?
-
How Much Debt Does Travere Therapeutics Have?
Total long term debt quarterly is $377.3M -
How Much Cash Does Travere Therapeutics Have?
Cash and short term investments quarterly total is $566.9M -
What Is Travere Therapeutics’s Book Value Per Share?
Book value per share is 2.66
Is Travere Therapeutics Cash Flow Positive?
-
What Is TVTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$280M -
What Is Travere Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $218.8M -
What Is Travere Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $55.8M
Travere Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
TVTX return on invested capital is -20.55% -
What Is Travere Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -14.51% -
What Is TVTX Return On Equity?
ROE is a measure of profitability and is -67.19%
Travere Therapeutics Earnings Date & Stock Price
-
What Is Travere Therapeutics's Stock Price Today?
A single share of TVTX can be purchased today for 6.2600 -
What Is Travere Therapeutics’s Stock Symbol?
Travere Therapeutics trades on the nasdaq under the ticker symbol: TVTX -
When Is Travere Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Travere Therapeutics is scheduled on May 6, 2024 -
When Is TVTX's next ex-dividend date?
Travere Therapeutics's next ex-dividend date is May 6, 2024 -
How To Buy Travere Therapeutics Stock?
You can buy Travere Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Travere Therapeutics Competitors
-
Who Are Travere Therapeutics's Competitors?
Below is a list of companies who compete with Travere Therapeutics or are related in some way:
Travere Therapeutics Dividend Yield
Data Unavailable
Travere Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -2.05% |
| Revenue: | 53.58% | 7.76% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 5 |
| Sell Recommendations: | 0 |
| Price Target: | 14.7857 |
| Upside from Last Price: | 136.19% |